SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068673
Filing Date
2024-08-14
Accepted
2024-08-14 10:29:43
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210923-10q_60degrees.htm   iXBRL 10-Q 1102464
2 CERTIFICATION ea021092301ex31-1_60degrees.htm EX-31.1 14108
3 CERTIFICATION ea021092301ex31-2_60degrees.htm EX-31.2 13918
4 CERTIFICATION ea021092301ex32-1_60degrees.htm EX-32.1 5899
5 CERTIFICATION ea021092301ex32-2_60degrees.htm EX-32.2 5935
  Complete submission text file 0001213900-24-068673.txt   6993164

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sxtp-20240630.xsd EX-101.SCH 67748
7 XBRL CALCULATION FILE sxtp-20240630_cal.xml EX-101.CAL 54610
8 XBRL DEFINITION FILE sxtp-20240630_def.xml EX-101.DEF 365613
9 XBRL LABEL FILE sxtp-20240630_lab.xml EX-101.LAB 638248
10 XBRL PRESENTATION FILE sxtp-20240630_pre.xml EX-101.PRE 363429
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0210923-10q_60degrees_htm.xml XML 743036
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 241205041
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)